AbbVie Inc. (NYSE:ABBV)

Prescription Drugs, Pills

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

The short interest data have been released for the June 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Medical interface

6 Biopharma Movers Making a Run on Wednesday

The broad markets appeared to be turning around in Wednesday’s session after posting losses in the past four sessions. One reason for this resurgence is a few biopharma companies making ...
Read Full Story »
crash

Why Infinity Pharmaceuticals Crashed

Infinity Pharmaceuticals Inc. (NASDAQ: INFI) saw perhaps making the biggest drop in the market on Tuesday, with shares plummeting by over two-thirds following a clinical mid-stage trial update. Though the company ...
Read Full Story »
Doctor, Health (pulse) copy

Analysts Very Positive on 3 Top Stocks Following Jefferies Healthcare Conference

If it’s summertime then it is Wall Street conference time, because when the weather heats up so does the conference schedule. With the Jefferies Healthcare Conference wrapping up in New ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Abbvie, Amazon, Cliffs Natural, Corning, Dynegy, Joy Global, Stanley Black & Decker and More

Stocks were indicated handily lower as bond yields are hitting record low in  Germany, the United Kingdom and Japan as worries of more global slowing are rubbing off to where ...
Read Full Story »
Medicine pills

Major Pharma Has Short Sellers on the Run

The short interest data have been released for the May 31 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
investing

4 Jefferies Franchise List Dividend Stocks to Buy Now

With the S&P 500 trading in a tight 3% range for almost three months, when there is a big move up or down it’s very possible it could be violent, ...
Read Full Story »
Medicine pills

How Credit Suisse Views Major Pharma After ASCO

The American Society of Clinical Oncology (ASCO) annual meeting is absolutely making waves in the pharmaceutical industry. As a result, analysts are giving their two cents on companies making presentations ...
Read Full Story »
Female patient on gurney

Merrill Lynch Picks ASCO Winners

The health care sector is descending on Chicago as the American Society of Clinical Oncology (ASCO) annual meeting nears. This meeting draws many companies and analysts alike, looking for the ...
Read Full Story »
Pfizer

4 UBS Most Preferred Pharmaceutical Stocks That Pay Big Dividends

Needless to say, the health care sector, especially pharmaceuticals and biotech, have taken a rhetorical beating from politicians looking to force the blame for high drug prices on some of the ...
Read Full Story »
white pills

Short Sellers Take Mixed Stance on Major Pharma

The short interest data have been released for the May 13 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
child with cancer

ASCO Could Make or Break These 7 Cancer Drug Trials

It is now getting close to the middle of May, and that means one thing for biotech investors. The king of biotech and pharma events is about to take place. ...
Read Full Story »
white pills

Major Pharma Short Interest Continues to Recede

The short interest data have been released for the April 29 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Medicine pills

3 Big Pharma Stocks With Credible Threats to Their Blockbusters

A pharmaceutical company could face a threat to one of its products for a number of reasons, ranging from an improved formulation, a new drug approval to simply a patent expiry and the ...
Read Full Story »
white pills

Why AbbVie Earnings Failed to Impress Investors

AbbVie Inc. (NYSE: ABBV) reported its first-quarter financial results before the markets opened on Thursday. The company said it had $1.15 in earnings per share (EPS) on $5.96 billion in ...
Read Full Story »